Company

Lupin

Lupin has 30 drugs tracked on RxWires: 2 post-market, 15 approved, 7 in Phase 3, 1 in Phase 2/3, 1 in Phase 2, 3 in Phase 1.

Pipeline

Drug	Phase	Indication
Lupin's Pegfilgrastim	Post-Market	Breast Cancer
Secnidazole	Post-Market	Bacterial Vaginoses
PITOLISANT HYDROCHLORIDE	Approved
RIVAROXABAN	Approved
LISINOPRIL	Approved
SODIUM ZIRCONIUM CYCLOSILICATE	Approved
DOXYCYCLINE	Approved
PREDNISOLONE ACETATE	Approved
TESTOSTERONE	Approved
FORMOTEROL FUMARATE	Approved
VYFEMLA	Approved
DOXYCYCLINE HYCLATE	Approved
MINOCYCLINE HYDROCHLORIDE	Approved
PREGABALIN	Approved
VANCOMYCIN HYDROCHLORIDE	Approved
CYANOCOBALAMIN	Approved
NYSTATIN AND TRIAMCINOLONE ACETONIDE	Approved
Granular powder in unit dose foil-lined sachet Mexiletine (PR)	Phase 3	Myotonia
Test Product (tiotropium bromide inhalation powder)	Phase 3	Chronic Obstructive Pulmonary Disease
Mexiletine granules for prolonged-release oral suspension	Phase 3	Myotonic Dystrophy
methacholine chloride	Phase 3	Mild Persistent Asthma
Mexiletine 167 mg	Phase 3	Myotonic Dystrophy Type 1 and Type 2
Escitalopram	Phase 3	Bipolar I Disorder
LUBT010 (proposed ranibizumab biosimilar)	Phase 3	Neovascular Age-related Macular Degeneration
Secnidazole 2 GM Oral Granules	Phase 2/3	Recurrent Bacterial Vaginosis
LSP-5415	Phase 2	Pregnancy Prevention
Ropinirole hydrochloride CR Tablets 2mg	Phase 1	Pharmacokinetic Study
LNP1892	Phase 1
LNP3794	Phase 1	NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors
Lamotrigine	Not Applicable	Non-Dystrophic Myotonia

Follow Lupin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.

Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.